Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914652 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anurag Purushothaman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Extracellular Vesicles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, CCSG High-Resolution Electron Microscopy Facility and Flow Cytometry and Cellular Imaging Core Facility.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) cells display extensive crosstalk with their surrounding environment to regulate tumor growth, immune evasion, and metastasis. Recent advances have attributed many of these interactions to intercellular communication mediated by small extracellular vesicles (sEVs), involving cancer-associated fibroblasts (CAF). To explore the impact of sEVs on monocyte lineage transition as well as the expression of checkpoint receptors and activation markers, peripheral blood monocytes from healthy subjects were exposed to PDAC-derived sEVs. Additionally, to analyze the role of sEV-associated HA in immune regulation and tissue-resident fibroblasts, monocytes and pancreatic stellate cells were cultured in the presence of PDAC sEVs with or depleted of HA. Exposure of monocytes to sEVs resulted in unique phenotypic changes in HLA-DR, PD-L1, CD86 and CD64 expression, and cytokine secretion that was HA-independent except for IL-1β and MIP1β. In contrast, monocyte suppression of autologous T cell proliferation was reduced following exposure to HA-low sEVs. In addition, exposure of stellate cells to sEVs upregulated the secretion of various cytokines, including MMP-9, while removal of HA from PDAC-derived sEVs attenuated the secretion of MMP-9, demonstrating the role of sEV-associated HA in regulating expression of this pro-tumorigenic cytokine from stellate cells. This observation lends credence to the findings from the TCGA database that PDAC patients with high levels of enzymes in the HA synthesis pathway had worse survival rates compared with patients having low expression of these enzymes. PDAC-derived sEVs have an immune modulatory role affecting the activation state of monocyte subtypes. However, sEV-associated HA does not affect monocyte phenotype but alters cytokine secretion and suppression of autologous T cell proliferation and induces secretion of pro-tumorigenic factors by pancreatic stellate cells (PSC), as has been seen following the conversion of PSCs to cancer-associated fibroblasts (CAFs). Interruption of the hexosamine biosynthetic pathway, activated in PDAC producing the key substrate (UDP-GlcNAc) for HA synthesis, thus, represents a potential clinical interception strategy for PDAC patients. Findings warrant further investigations of underlying mechanisms involving larger sample cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
- Ahmed Center for Pancreatic Cancer Research, MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Dan L Duncan Cancer Center, Advanced Technology Core, Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Jacqueline Oliva-Ramírez, Warapen Treekitkarnmongkol, Deivendran Sankaran, Anirban Maitra, Cara Haymaker
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- CCSG High-Resolution Electron Microscopy Facility and Flow Cytometry and Cellular Imaging Core Facility
- CPRIT Proteomics and Metabolomics Core Facility
- Dan L. Duncan Cancer Center
- MD Anderson Pancreatic Cancer Moon Shot Program, the Sheikh Khalifa Bin Zayed Al-Nahyan Foundation
- Translational Molecular Pathology-Immunoprofiling Lab (TMP-IL) at the Department of Translational Molecular Pathology, the University of Texas MD Anderson Canc…
Zitieren
APA
Purushothaman, A., Oliva-Ramírez, J., Treekitkarnmongkol, W., Sankaran, D., Hurd, M. W., Putluri, N., Maitra, A., Haymaker, C., & Sen, S. (2023). Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914652
Vancouver
Purushothaman A, Oliva-Ramírez J, Treekitkarnmongkol W, Sankaran D, Hurd MW, Putluri N, et al. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914652
BibTeX
@article{Purushothaman2023,
author = {Purushothaman, Anurag and Oliva-Ramírez, Jacqueline and Treekitkarnmongkol, Warapen and Sankaran, Deivendran and Hurd, Mark W and Putluri, Nagireddy and Maitra, Anirban and Haymaker, Cara and Sen, Subrata},
title = {Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914652}
}
EUVIMED